Brian D. Richards
Clinical Psychology · 2011–2016
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 4 researchers here, as inferred from the citation graph.
Subfields
- Clinical Psychology — 15 citations into it; #4,190 of 8,024 by trust here, #3,928 by citations
Whom Brian D. Richards trusts
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Brian D. Richards
- David E. Nichols (in Clinical Psychology)
- Robin L. Carhart-Harris (in Clinical Psychology)
- Roland R. Griffiths (in Clinical Psychology)
- Matthew W. Johnson (in Clinical Psychology)
Papers from Brian D. Richards's perspective
Ordered by how strongly the researchers Brian D. Richards trusts endorse each paper. Same corpus, a different order for every researcher.
- Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
- Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. (Archives of General Psychiatry)
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (Psychopharmacology)
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (Journal of Psychopharmacology)
- Optimism, coping, and health: assessment and implications of generalized outcome expectancies. (Health Psychology)
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases (Journal of Nervous and Mental Disease)
- Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects (Psychopharmacology)
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders (Nature Reviews Neuroscience)